Cara Therapeutics
CARA
$0.67
Share price
-5.02%
Change (1 day)
-83.21%
Change (1 year)
Categories
Cara Therapeutics (CARA) - Total debt
Total debt on the balance sheet as of December 2023 : $6.08 M
According to Cara Therapeutics 's latest financial reports the company's total debt is $6.08 M. A company’s total debt is the sum of all current and non-current debts.
Cara Therapeutics - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $6.08 M | 217.41% |
| 2022-12-31 | $1.91 M | -47.78% |
| 2021-12-31 | $3.67 M | -30.37% |
| 2020-12-31 | $5.27 M | 22.13% |
| 2019-12-31 | $4.31 M | |
| 2018-12-31 | $N/A | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $0.78 M | 3.59% |
| 2011-12-31 | $0.75 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 481,700.26% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 1,163,582.65% | 🇺🇸 USA |
 Trevena TRVN | $35.31 M | 480.04% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.18 B | 2,956.65% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $3.36 M | -44.66% | 🇺🇸 USA |